PREVALENCE OF PERSISTENT LIPID ABNORMALITIES IN HIGH-RISK PATIENTS TREATED WITH STATINS: RESULTS OF THE DYSLIPIDEMIA INTERNATIONAL STUDY IN THE UK

被引:0
|
作者
Kotseva, K. [1 ]
Bowker, T. [2 ]
Jennings, C. [1 ]
Turner, E. [3 ]
Amber, V. [1 ]
Wood, D. [1 ]
机构
[1] Imperial Coll London, Natl Heart & Lung Inst, London, England
[2] Homerton Univ Hosp NHS Trust, Dept Cardiol, London, England
[3] London Sch Hyg & Trop Med, Dept Epidemiol & Publ Hlth, London WC1, England
关键词
D O I
10.1136/hrt.2010.196089.11
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A68 / A68
页数:1
相关论文
共 50 条
  • [21] Dyslipemia in diabetics treated with statins. Results of the Dyslipidemia International Study in Spain
    Millan, Jesus
    Alegria, Eduardo
    Guijarro, Carlos
    Lozano, Jose V.
    Vitale, Gustavo C.
    Gonzalez-Timon, Belen
    Gonzalez-Juanatey, Jose R.
    MEDICINA CLINICA, 2013, 141 (10): : 430 - 436
  • [22] Persistent dyslipidemia in Chinese patients treated with lipid-lowering drugs: interim results of the dyslipidaemia international study (DYSIS) China
    Hu, D. Y.
    Wang, Y. J.
    Zhao, S. P.
    Mu, Y. M.
    EUROPEAN HEART JOURNAL, 2013, 34 : 797 - 797
  • [23] Prevalence of lipid abnormalities among coronary patients remains high in the Middle East/ Africa region: the Dyslipidemia International Study (DYSIS) II MEA results
    Al Sifri, S. N.
    Al Mahmeed, W.
    Azar, R.
    Sobhy, M.
    Gitt, A. K.
    Horack, M.
    Ashton, V.
    Brudi, P.
    Ambegaonkar, B.
    Wajih, S.
    EUROPEAN HEART JOURNAL, 2015, 36 : 288 - 288
  • [24] Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study
    Leiter, L. A.
    Lundman, P.
    da Silva, P. M.
    Drexel, H.
    Juenger, C.
    Gitt, A. K.
    DIABETIC MEDICINE, 2011, 28 (11) : 1343 - 1351
  • [25] Prevalence of lipid disorders in statin treated patients from Sweden, Norway and Denmark: Results from the Dyslipidemia International Study (DYSIS)
    Thomsen, K. Korsgaard
    Lundman, P.
    Salling, S.
    Journath, G.
    Pedersen, T.
    EUROPEAN HEART JOURNAL, 2009, 30 : 514 - 515
  • [26] Prevalence of lipid disorders in statin treated patients from Sweden, Norway and Denmark: results from the Dyslipidemia International Study (DYSIS)
    Thomsen, Kristian Korsgaard
    Salling, Soren
    Lundman, Pia
    Journath, Gunilla
    Pedersen, Terje
    CARDIOLOGY, 2009, 113 : 116 - 116
  • [27] Strong Statins as the Major Players for Dyslipidemia in High-Risk Patients - Are They All the Same or Not?
    Ikewaki, Katsunori
    Ayaori, Makoto
    CIRCULATION JOURNAL, 2011, 75 (06) : 1326 - 1327
  • [28] LIPID ABNORMALITIES REMAIN HIGH AMONG DIABETIC PATIENTS WITH STABLE CHD: RESULTS OF THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS) II BELGIUM
    Hermans, M.
    Cools, F.
    Gevaert, S.
    Missault, L.
    Gitt, A.
    Horack, M.
    Ashton, V.
    Brudi, P.
    Lautsch, D.
    Ambegaonkar, B.
    ATHEROSCLEROSIS, 2015, 241 (01) : E130 - E130
  • [29] The DYSlipidemia International Study (DYSIS)-Egypt: A report on the prevalence of lipid abnormalities in Egyptian patients on chronic statin treatment
    El Etriby, Adel
    Bramlage, Peter
    El Nashar, Amany
    Brudi, Philippe
    EGYPTIAN HEART JOURNAL, 2013, 65 (03): : 223 - 232
  • [30] Percentage lipid abnormalities in statin treated patients. The dyslipidemia international survey study (DYSIS-SPAIN)
    Gonzalez-Juanatey, J. R.
    Millan, J.
    Guijarro, C.
    Alegria, E.
    Lozano, J. V.
    Inaraja, V.
    Vitale, G.
    Cea-Calvo, L.
    EUROPEAN HEART JOURNAL, 2009, 30 : 373 - 373